Hydromed

Hydrochlorothiazide, the active ingredient in Hydromed, is a thiazide diuretic presented as an oral tablet for oral administration. It works by promoting the excretion of sodium and water, thereby helping to lower elevated blood pressure and to decrease fluid retention associated with edema and related cardiovascular conditions.

GNH USA supplies Hydromed as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics across global markets while adhering to stringent quality and regulatory standards and supporting reliable medication access for patients worldwide.

Hydrochlorothiazide is a thiazide diuretic that reduces extracellular fluid volume, making it useful in several cardiovascular conditions.

- Hypertension: lowers systemic blood pressure by decreasing plasma volume. - Edema: reduces fluid accumulation in peripheral tissues, improving swelling. - Congestive heart failure: assists in fluid management and symptom relief.

Hydrochlorothiazide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Increased urination: more frequent need to void. - Dizziness or light‑headedness, especially on standing. - Electrolyte imbalance: low potassium or sodium levels. - Elevated blood glucose: may affect diabetic control. - Gout flare: increased uric acid concentrations. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss leading to hypotension. - Acute kidney injury: sudden decline in renal function. - Life‑threatening electrolyte disturbances: severe hypokalemia or hyponatremia. - Pancreatitis: inflammation of the pancreas. - Anaphylactic reaction: rare but potentially fatal allergy. - Blood dyscrasias: abnormal blood cell counts such as agranulocytosis.

Before initiating therapy, consider the following safety measures.

- Monitor electrolytes: check serum potassium, sodium, and magnesium regularly. - Assess renal function: evaluate creatinine clearance and adjust use if impaired. - Use caution in diabetes: may worsen glycemic control, requiring closer monitoring. - Adjust dose in the elderly: start low and titrate slowly due to increased sensitivity. - Avoid in severe hepatic impairment: risk of accumulation and toxicity. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Hydrochlorothiazide can affect the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Lithium: concurrent use can increase lithium levels and toxicity. - Cyclosporine: combined therapy may heighten nephrotoxic risk. - NSAIDs (e.g., ibuprofen): may reduce diuretic efficacy and impair renal function. - ACE inhibitors/ARBs: can cause unpredictable potassium shifts.

Moderate Interactions (Monitor Closely): - Antidiabetic agents (insulin, sulfonylureas): may require dose reduction due to enhanced hypoglycaemic effect. - Digoxin: risk of toxicity may increase with electrolyte disturbances. - Warfarin: potentiation of anticoagulant effect may occur. - Quinolone antibiotics: may increase seizure risk in susceptible patients.